The customer observed falsely elevated insulin patient results generated using the architect insulin reagents.The following data was provided (uu/ml).Sid (b)(6) result 72.80.Previous results for the patient were provided, 27.4, 34.7.Dilution linearity testing results ranged from 21.60 to 28.80.The patient is an (b)(6) weighing less than (b)(6).The mother of the (b)(6) is a diabetic patient.No impact to patient management was reported.
|
Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, a review of field data, a review of labeling, and accuracy testing.No adverse trend was identified for the customer's issue.Review of field data found the complaint lot performance was comparable to other lots, and no issue was found.Labeling was reviewed and found to be adequate.Device history review did not identify any issues that may have caused the customer issue.The product was not available for return.An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications.Based on all available information and abbott diagnostics complaint investigation, the assay performed as intended and no product deficiency was identified.
|